AVUV vs XLV
Avantis US Small Cap Value ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.25% for AVUV.
- • XLV pays a higher dividend yield (1.60%).
Side-by-side metrics
| Metric | AVUV | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.25% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.25% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $29.06B | $40.60B |
YTD return | 20.76% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 0.51 |
P/E ratio | 13.57 | 29.12 |
Last price | $123.50 | $161.81 |
Inception | — | — |
Issuer | Avantis | State Street |
AVUV top holdings
| VSAT | Viasat Inc | 1.39% |
| MATX | Matson Inc | 1.02% |
| LNTH | Lantheus Holdings Inc | 0.86% |
| IRDM | Iridium Communications Inc | 0.78% |
| AVT | Avnet Inc | 0.78% |
| M | Macy's Inc | 0.76% |
| LEA | Lear Corp | 0.75% |
| GATX | GATX Corp | 0.74% |
| AROC | Archrock Inc | 0.73% |
| CBT | Cabot Corp | 0.73% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About AVUV
AVUV (Avantis US Small Cap Value ETF) is US small-cap value with profitability screen. Managed by Avantis, the fund carries $29.1B in assets under management, an expense ratio of 0.25%, a dividend yield of 1.25%. Its largest holding is Viasat Inc (VSAT), which represents 1.4% of the portfolio. Real Estate is the fund's largest sector exposure at 0.7%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.